All About Cardiovascular System and Disorders

Fondaparinux is a synthetic polysaccharide which is an indirect, selective factor Xa inhibitor.

Estimation of left ventricular filling pressures from tissue Doppler data can be obtained from the correlations obtained from previous comparisons with cath

Omecamtiv mecarbil is a cardiac myosin activator being evaluated in the treatment of heart failure.

Ambulatory BP monitoring and home monitoring are two methods which have been developed to assess the ‘true’ blood pressure in an ideal setting.

ANTIPAF-Trial concluded that one year treatment with ARB in AF and no structural heart disease did not reduce the burden of paroxysmal AF.

Stent was superior to balloon angioplasty and surgery was superior to stent in coarctation of aorta, but with longer hospital stay.

High prevalence and high spontaneous closure rates of muscular VSDs have been noted by echocardiographic screening in neonates.

PCI in CAD associated with severe aortic stenosis could be performed no significant increased risk of short term mortality.

Polymer free amphilimus stent has lower in stent late lumen loss and better 1 year clinical safety and efficacy in treatment of de novo coronary lesions.

Newer antithrombotics in atrial fibrillation: DTI -dabigatran, direct factor Xa inhibitors - rivaroxaban, apixaban, edoxaban; vitamin K analogue tecarfarin.